Harrow Launches HarrowRx Platform for Ophthalmic Prescribing in North America
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Harrow launched HarrowRx, a prescribing and access pharmacy platform in North America. This platform, which is powered by PhilRx, enables eyecare professionals to access Harrow’s entire product portfolio directly within the Electronic Medical Record (EMR) systems they already use.
From manilatimes.net
Why it matters
HarrowRx integrates prescribing with product-specific fulfillment and patient-support services. The company states that HarrowRx is the first platform of its kind developed by a U.S. ophthalmic pharmaceutical company.
From manilatimes.net
Who's involved
- North AmericaThe geographic market where the new prescribing platform was launched